CRH Medical Corporation Announces Voting Results of its 2017 Annual General Meeting of Shareholders

VANCOUVER, June 9, 2017

Nominee	Votes For	%	Votes Withheld	%
Dr. Anthony Holler ARIVA.DE Börsen-Geflüster Kurse CRH Medical -   0,00%	36,281,626	97.02	1,114,101	2.98
Dr. David Johnson	37,207,572	99.50	188,155	0.50
Mr. Todd Patrick	36,281,326	97.02	1,114,401	2.98
Mr. Ian Webb	36,280,871	97.02	1,114,856	2.98
Mr. Edward Wright	37,196,400	99.47	199,287	0.53

At the Meeting, shareholders of the Company also approved the appointment of KPMG LLP as auditor of the Company.

In addition the Company's shareholders approved the Company's 2017 Share Unit Plan.

Detailed voting results for the Meeting can be found on SEDAR at www.sedar.com 

About CRH Medical Corporation

CRH Medical Corporation is a North American company focused on providing gastroenterologists throughout the United States with innovative services and products for the treatment of gastrointestinal diseases. The CRH O'Regan System is a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids. CRH distributes the O'Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to gastroenterology practices, creating meaningful relationships with the gastroenterologists it serves. CRH's O'Regan System is currently used in all 48 lower US states.

In 2014, CRH acquired Gastroenterology Anesthesia Associates, LLC ("GAA"), a full-service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures. Since then, CRH has incorporated ten additional acquisitions to its anesthesia business. CRH Anesthesia now services 27 ambulatory surgical centers in seven states and performs approximately 185,000 procedures annually.

SOURCE CRH Medical Corporation